Vous n'êtes pas identifié (connexion)

Centre de recherche

VENDREDI 15 DÉC

Calendrier >

CARRIÈRES

Liste des opportunités >

BOTTIN

Jean-Mathieu Beauregard

Formation
à venir

Aucune offre active

Autres opportunités de carrière
Axe principal
Oncologie
Adresse(s)
Hôtel-Dieu de Québec
6, rue McMahon
00896-5
Québec (Québec)
CANADA G1R 2J6

Téléphone(s)
+1 418-525-4444, poste 15455
Télécopieur(s)
+1 418-691-5268
Courriel(s)
jean-mathieu.beauregard@chuq.qc.ca

Projet(s) de recherche actif(s)

Aucun projet de recherche à afficher

Publications récentes (voir toutes les publications de ce chercheur)

Espagnet R, Frezza A, Martin JP, Hamel LA, Lechippey L, Beauregard JM, Despres P. A CZT-based blood counter for quantitative molecular imaging. EJNMMI physics,  2017. 4: 18
Del Prete M, Buteau FA, Beauregard JM. Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study. European journal of nuclear medicine and molecular imaging,  2017. 44: 1490-1500
Uribe CF, Esquinas PL, Tanguay J, Gonzalez M, Gaudin E, Beauregard JM, Celler A. Accuracy of 177Lu activity quantification in SPECT imaging: a phantom study. EJNMMI physics,  2017. 4: 2
Morin F, Beauregard JM, Bergeron M, Nguile Makao M, Lacombe L, Fradet V, Fradet Y, Pouliot F. Metabolic Imaging of Prostate Cancer Reveals Intrapatient Intermetastasis Response Heterogeneity to Systemic Therapy. European urology focus,  2017. Epub
Bergeron D, Beauregard JM, Guimond J, Fortin MP, Houde M, Poulin S, Verret L, Bouchard RW, Laforce R. Clinical Impact of a Second FDG-PET in Atypical/Unclear Dementia Syndromes. Journal of Alzheimer's disease : JAD,  2016. 49: 695-705
Bensaidane MR, Beauregard JM, Poulin S, Buteau FA, Guimond J, Bergeron D, Verret L, Fortin MP, Houde M, Bouchard RW, Soucy JP, Laforce R. Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers. Journal of Alzheimer's disease : JAD,  2016. 52: 1251-62
Beauregard JM, Beaulieu A. How we read FCH-PET/CT for prostate cancer. Cancer imaging : the official publication of the International Cancer Imaging Society,  2016. Epub
Beauregard JM, Blouin AC, Fradet V, Caron A, Fradet Y, Lemay C, Lacombe L, Dujardin T, Tiguert R, Rimac G, Bouchard F, Pouliot F. FDG-PET/CT for pre-operative staging and prognostic stratification of patients with high-grade prostate cancer at biopsy. Cancer imaging : the official publication of the International Cancer Imaging Society,  2015. 15: 2
Iliuta IA, Beauregard JM, Couture F, Douville P, Mac-Way F. Reversal of Severe and Refractory Humoral Hypercalcemia With 177Lu-Octreotate Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumor of the Pancreas. Clinical nuclear medicine,  2015. 40: e448-50
Beauregard JM, Pouliot F. New developments in the imaging of metastatic prostate cancer. Current opinion in supportive and palliative care,  2014. 8: 265-70
© 2017 Tous droits réservés Centre de recherche du CHU de Québec